BDF-3299 is a small molecule that has been investigated for its potential use in treating various conditions, including certain types of cancer. It is primarily known as a selective inhibitor of the protein MCL-1 (myeloid cell leukemia 1), which plays a role in regulating cell survival and apoptosis. By inhibiting MCL-1, BDF-3299 may help to induce cell death in cancer cells that are dependent on this protein for survival.
New to topics? Read the docs here!